Organon & Co. Other Comprehensive Income (Loss), Tax
Organon & Co. (OGN) reported Other Comprehensive Income (Loss), Tax of -$1.00 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-28.
Financial Statements › Expense Statement › Income Tax
us-gaap:OtherComprehensiveIncomeLossTax · last filed 2025-02-28
- Organon & Co. other comprehensive income (loss), tax for the quarter ending 2024-12-31 was -$1.00M.
- Organon & Co. other comprehensive income (loss), tax for the quarter ending 2024-09-30 was $0.00.
- Organon & Co. other comprehensive income (loss), tax for the quarter ending 2024-06-30 was $0.00.
- Organon & Co. other comprehensive income (loss), tax for the quarter ending 2024-03-31 was $0.00.
- Organon & Co. other comprehensive income (loss), tax for fiscal 2024 was -$1.00M.
- Organon & Co. other comprehensive income (loss), tax for fiscal 2023 was -$4.00M, a 180.00% decline from fiscal 2022.
- Organon & Co. other comprehensive income (loss), tax for fiscal 2022 was $5.00M, a 61.54% decline from fiscal 2021.
- Organon & Co. other comprehensive income (loss), tax for fiscal 2021 was $13.00M.
| Period end | Other Comprehensive Income (Loss), Tax 3 month | Other Comprehensive Income (Loss), Tax 6 month | Other Comprehensive Income (Loss), Tax 9 month | Other Comprehensive Income (Loss), Tax 12 month |
|---|---|---|---|---|
| 2024-12-31 | -$1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | -$1.00M derived: sum of 2 quarters · filed 2025-02-28 | -$1.00M derived: sum of 3 quarters · filed 2025-02-28 | -$1.00M 10-K · filed 2025-02-28 |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-01 | $0.00 derived: sum of 2 quarters · filed 2024-11-01 | $0.00 10-Q · filed 2024-11-01 | -$4.00M derived: sum of 4 quarters · filed 2025-02-28 |
| 2024-06-30 | $0.00 10-Q · filed 2024-08-07 | $0.00 10-Q · filed 2024-08-07 | -$4.00M derived: sum of 3 quarters · filed 2025-02-28 | -$4.00M derived: sum of 4 quarters · filed 2025-02-28 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-03 | -$4.00M derived: sum of 2 quarters · filed 2025-02-28 | -$4.00M derived: sum of 3 quarters · filed 2025-02-28 | -$4.00M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-12-31 | -$4.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | -$4.00M derived: sum of 2 quarters · filed 2025-02-28 | -$4.00M derived: sum of 3 quarters · filed 2025-02-28 | -$4.00M 10-K · filed 2025-02-28 |
| 2023-09-30 | $0.00 10-Q · filed 2024-11-01 | $0.00 derived: sum of 2 quarters · filed 2024-11-01 | $0.00 10-Q · filed 2024-11-01 | $6.00M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $0.00 10-Q · filed 2024-08-07 | $0.00 10-Q · filed 2024-08-07 | $6.00M derived: sum of 3 quarters · filed 2025-02-28 | $6.00M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-03 | $6.00M derived: sum of 2 quarters · filed 2025-02-28 | $6.00M derived: sum of 3 quarters · filed 2025-02-28 | $5.00M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $6.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $6.00M derived: sum of 2 quarters · filed 2025-02-28 | $5.00M derived: sum of 3 quarters · filed 2025-02-28 | $5.00M 10-K · filed 2025-02-28 |
| 2022-09-30 | $0.00 10-Q · filed 2023-11-03 | -$1.00M derived: sum of 2 quarters · filed 2023-11-03 | -$1.00M 10-Q · filed 2023-11-03 | $2.00M derived: sum of 4 quarters · filed 2024-02-26 |
| 2022-06-30 | -$1.00M 10-Q · filed 2023-08-09 | -$1.00M 10-Q · filed 2023-08-09 | $2.00M derived: sum of 3 quarters · filed 2024-02-26 | $2.00M derived: sum of 4 quarters · filed 2024-02-26 |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-05 | $3.00M derived: sum of 2 quarters · filed 2024-02-26 | $3.00M derived: sum of 3 quarters · filed 2024-02-26 | $9.00M derived: sum of 4 quarters · filed 2024-02-26 |
| 2021-12-31 | $3.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | $3.00M derived: sum of 2 quarters · filed 2024-02-26 | $9.00M derived: sum of 3 quarters · filed 2024-02-26 | $13.00M 10-K · filed 2024-02-26 |
| 2021-09-30 | $0.00 10-Q · filed 2022-11-04 | $6.00M derived: sum of 2 quarters · filed 2022-11-04 | $10.00M 10-Q · filed 2022-11-04 | -$23.00M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-06-30 | $6.00M 10-Q · filed 2022-08-05 | $10.00M 10-Q · filed 2022-08-05 | -$23.00M derived: sum of 3 quarters · filed 2023-02-27 | -$23.00M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-03-31 | $3.00M 10-Q · filed 2022-05-06 | -$29.00M derived: sum of 2 quarters · filed 2023-02-27 | -$29.00M derived: sum of 3 quarters · filed 2023-02-27 | -$28.00M derived: sum of 4 quarters · filed 2023-02-27 |
| 2020-12-31 | -$32.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | -$32.00M derived: sum of 2 quarters · filed 2023-02-27 | -$31.00M derived: sum of 3 quarters · filed 2023-02-27 | -$29.00M 10-K · filed 2023-02-27 |
| 2020-09-30 | $0.00 10-Q · filed 2021-11-12 | $1.00M derived: sum of 2 quarters · filed 2021-11-12 | $3.00M 10-Q · filed 2021-11-12 | |
| 2020-06-30 | $1.00M 10-Q · filed 2021-08-16 | $3.00M 10-Q · filed 2021-08-16 | ||
| 2020-03-31 | $2.00M 10-Q · filed 2021-06-21 | |||
| 2019-12-31 | -$8.00M 10-K · filed 2022-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 | |
| ACADIA PHARMACEUTICALS INC (ACAD) | United States | $3.823B | 11.45 |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 | |
| Enliven Therapeutics, Inc. (ELVN) | United States | $3.307B | -35.07 |
| Arcutis Biotherapeutics, Inc. (ARQT) | United States | $3.303B | 115.47 |
| Arcus Biosciences, Inc. (RCUS) | United States | $3.188B | -8.52 |
| Dyne Therapeutics, Inc. (DYN) | United States | $3.084B | -7.09 |
| Tango Therapeutics, Inc. (TNGX) | United States | $4.154B | -42.53 |